Implantable medical devices and related methods of use

Patent metadata

Field	Value
Publication number	US-10232154-B2
Application number	US-201615221110-A
Country	US
Kind code	B2
Filing date	Jul 27, 2016
Priority date	Jul 28, 2015
Publication date	Mar 19, 2019
Grant date	Mar 19, 2019

Abstract

A medical system may include an elongate member having a proximal end and a distal end, the elongate member being movable between a collapsed configuration and an expanded configuration, and a first therapeutic agent configured to treat a condition of the lung.

First claim

What is claimed is:

1. A method of treating a lung, the method including:
determining a size of an airway of the lung;
selecting a size of a first member to be inserted into the airway of the lung based on the size of the airway, to prevent damage to the airway;
inserting the first member into the airway of the lung via a catheter while the first member is in a collapsed radial configuration;
delivering the first member from a distal end of the catheter, wherein the first member converts to an expanded radial configuration after exiting the catheter such that an outer radial surface of the first member contacts tissue defining the airway; and
delivering a first therapeutic agent to the lung;
wherein, while in the expanded radial configuration, the first member forms a coil with a first portion and a distalmost portion, the first portion having a first outer diameter, and the distalmost portion having a second outer diameter that is less the first outer diameter.

2. The method of claim 1 , wherein the first therapeutic agent is configured to treat COPD and asthma.

3. The method of claim 1 , further including interlocking a delivery member disposed within the catheter to the first member.

4. The method of claim 3 , further including releasing the first member from the delivery member after the first member exits the distal end of the catheter.

5. The method of claim 1 , wherein the first therapeutic agent is disposed within a lumen of the first member, the outer radial surface of the first member is permeable, and the first therapeutic agent is delivered to the lung through the permeable outer radial surface of the first member.

6. The method of claim 1 , wherein the coil is an expandable coil, and the method further includes anchoring the expandable coil in the airway wall with a bioabsorbable anchoring feature that pierces the tissue of the airway wall.

7. The method of claim 1 , wherein the distalmost portion does not contact tissue when the coil is at rest in the airway.

8. The method of claim 7 , wherein the first therapeutic agent includes a bronchodilator.

9. The method of claim 8 , further including delivering a second therapeutic agent from the coil, wherein the second therapeutic agent includes a steroid configured to reduce airway inflammation.

10. The method of claim 9 , wherein the bronchodilator includes one or more of albuterol, levalbuterol, and ipratropium, and the steroid includes one or more of fluticasone and budesonide.

Assignees

• Boston Scient Scimed Inc

Inventors

• O'Sullivan Conor
• O'Brien John-Alan
• Ryan Frank

Classifications

• A61M2210/1039

  Lungs · CPC title

• A61M31/002 Primary

  Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50) · CPC title